Ca2+ signaling is essential in vivo for T-ALL as demonstrated by increased survival of mice injected with STIM1/2-deficient [28] or mice infused with CnB1-deficient T-ALL cells [8] as compared to their control counterparts. The gene discussed is STIM1; the disease is acute lymphoblastic leukemia.